| Identification | Back Directory | [Name]
8-(4-CHLOROPHENYLTHIO)GUANOSINE 3',5'-CYCLIC MONOPHOSPHOTHIOATE, RP-ISOMER TRIETHYLAMMONIUM SALT | [CAS]
153660-04-9 | [Synonyms]
RP-8-PCPT-CGMPS RP-8-PCPT-CGMPS, TEA 8 PCPT-CGMPS NA, RP-ISOMER 8 PCPT-CGMPS TEA, RP-ISOMER RP-8-PCPT-CGMPS SODIUM SALT Rp-8-pCPT-cyclic GMPS Sodium RP-8-P-CPT-CGMPS TRIETHYLAMINE RP-8-[(4-CHLOROPHENYL)THIO]-CGMPS TRIETHYLAMINE rp-8-[(4-chlorophenyl)thio]-cgmps triethylammonium salt Guanosine, 8-[(4-chlorophenyl)thio]-, cyclic 3',5'-[hydrogen (R)-phosphorothioate] RP-8-[(4-CHLOROPHENYL)THIO]-GUANOSINE 3',5'-CYCLIC MONOPHOSPHOTHIOATE TRIETHYLAMINE 8-(4-CHLOROPHENYLTHIO)GUANOSINE 3',5'-CYCLIC MONOPHOSPHOTHIOATE, RP-ISOMER SODIUM SALT 8-(4-CHLOROPHENYLTHIO)GUANOSINE-3',5'-CYCLIC MONOPHOSPHOROTHIOATE SODIUM SALT, RP-ISOMER 8-(4-CHLOROPHENYLTHIO) GUANOSINE-3',5'-CYCLIC MONOPHOSPHOROTHIOATE, RP-ISOMER SODIUM SALT RP-8-[(4-CHLOROPHENYL)THIO]-GUANOSINE-CYCLIC 3',5'-HYDROGEN PHOSPHOROTHIOATE TRIETHYLAMINE 8-(4-chlorophenylthio)guanosine-3’,5’-cyclicmonophosphorothioate,rp-isomer(rp-8-pcpt-cgmps),sod 8-(4-CHLOROPHENYLTHIO)GUANOSINE 3',5'-CYCLIC MONOPHOSPHOTHIOATE, RP-ISOMER TRIETHYLAMMONIUM SALT 8-(4-chlorophenylthio)-guanosine 3',5'-cyclic monophosphorothioate, rp isomer triethylammonium salt GUANOSINE 3',5'-CYCLIC MONOPHOSPHOROTHIOATE, 8-(4-CHLOROPHENYLTHIO)-, RP-ISOMER, TRIETHYLAMMONIUM SALT Rp-8-[(4-Chlorophenyl)thio]-cGMPS triethylammonium salt, Rp-8-CPT-cGMPS, Rp-8-[(4-Chlorophenyl)thio]-guanosine-cyclic 3μ,5μ-hydrogen phosphorothioate triethylammonium salt | [Molecular Formula]
C16H15ClN5O6PS2 | [MDL Number]
MFCD01861936 | [MOL File]
153660-04-9.mol | [Molecular Weight]
503.88 |
| Hazard Information | Back Directory | [Uses]
Rp-8-pCPT-cGMPS is a competitive inhibitor of cGMP-dependent protein kinase (PKG) (Ki=0.5 μM). Rp-8-pCPT-cGMPS has high lipid solubility and can more easily penetrate the cell membrane and reach sufficient concentration inside the cell to inhibit cGMP-dependent protein kinase. Rp-8-pCPT-cGMPS can be used to study the activity and function of cGMP-dependent protein kinase in platelets[1]. | [Biological Activity]
Cell permeable: yes''Primary Target PKG1α''Product does not compete with ATP.''Reversible: no | [References]
[1] E Butt, et al. (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor. European Journal of Pharmacology: Molecular Pharmacology 269.2 (1994): 265-268. DOI:10.1016/0922-4106(94)90095-7 |
|
|